Tag Archive | "human papillomavirus"
BT Pharma secures EUR 13.1million (USD 17.7 million) in capital funding and changes its name to Genticel
Source: pharmalive.com/News Author: press release BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional de Développement [...]
Continue reading...OralDNA Labs introduces OraRisk HPV salivary diagnostic test
Tuesday, March 2, 2010
Source: www.rdhmag.com Author: press release OralDNA Labs , a leader in advancing wellness in dentistry through salivary diagnostics and a subsidiary of Quest Diagnostics, recently introduced a OraRisk HPV test. The test is a noninvasive, screening tool to identify the type(s) of oral human papillomavirus (also called HPV). Oral HPV is a mucosal viral infection that is a [...]
Continue reading...Tobacco use linked to worse outcomes In HPV-positive head and neck cancer, U-M study finds
Wednesday, February 17, 2010
Source: www.medicalnewstoday.com Author: Nicole Fawcett, University of Michigan Health System Patients with head and neck cancer linked to high risk human papillomavirus, or HPV, have worse outcomes if they are current or former tobacco users, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. High-risk HPVs are the same viruses that are [...]
Continue reading...HPV-linked head and throat cancers easier to treat unless patient is a smoker, University of Michigan study finds
Wednesday, February 17, 2010
Source: annarbor.com Author: Tina Reed A growing incidence of head and throat cancers have been traced back to the human papillomavirus, or HPV, rather than smoking. With that in mind, University of Michigan researchers recently decided to examine the difference in outcomes between smokers with HPV-linked head and throat cancer and those who had never smoked. Turns out, [...]
Continue reading...Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer
Saturday, February 13, 2010
Source: 7thspace.com Author: staff P16 and p53 protein expression, and high-risk human papillomavirus (HPV-HR) types have been associated with survival in head and neck cancer (HNC). Evidence suggests that multiple molecular pathways need to be targeted to improve the poor prognosis of HNC. Purpose: This study examined the individual and joint effects of tumor markers for differences in predicting [...]
Continue reading...Cervarix® vaccination against HPV lasts at least six years
Monday, December 7, 2009
Source: professional.cancerconsultants.com Author: staff Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.[1] Cervarix [...]
Continue reading...Papillomavirus silences innate immune response
Thursday, December 3, 2009
Source: www.sciencedaily.com Author: staff In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, [...]
Continue reading...A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma
Saturday, November 28, 2009
Source: Arch Otolaryngol Head Neck Surg, November 1, 2009; 135(11) Authors: JJ Jaber et al. Objective: To determine the recurrence and survival outcome based on treatment date, type of treatment, stage of disease, and comorbidity and the recurrence and survival differences based on smoking status as a surrogate for human papillomavirus status in veterans treated for tonsillar squamous [...]
Continue reading...HPV vaccine clears viral infection and may reduce cancerous lesions
Tuesday, November 10, 2009
Source: www.newswise.com Author: staff Breakthrough study reports complete and partial remissions following vaccination A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. According to a report published in the November 5 [...]
Continue reading...HPV vaccination: inaccurate assumptions about oropharyngeal cancer
Wednesday, November 4, 2009
Source: BMJ 2009;339:b4525 Author: Erich M Sturgis et al. Excerpt from article: The article by Kim and Goldie on the cost effectiveness of including boys in a human papillomavirus (HPV) vaccination programme made assumptions about oropharyngeal cancers that are inaccurate.1 The prevalence of HPV in oropharyngeal cancer used in the article (31%) is based on worldwide estimates,2 [...]
Continue reading...- Samuel Broder: Why Isn't There a Gardasil for Men?
- Snus news & other tobacco products
- High dosage brachytherapy obtains excellent results in head and neck tumors
- A vaccine debate once focused on sex shifts as boys join the target market
- Consistent evidence to support the use of xylitol- and sorbitol-containing chewing gum to prevent dental caries
- Bill would bar sales of dissolvable tobacco
- R. J. Reynolds introducing 'dissolvable' tobacco
- Smoking debate has become nicotine-delivery debate
- Israeli study sees link between oral cancer, cell phones
- Periodontitis associated with fourfold increased risk for squamous cell carcinoma of the head and neck
- hilllaguna: Negating that nicotine replacement therapies are p...
- OC Advocate: It comes a little surprise that this "test" which ...
- hilllaguna: By world medical treatment standards a diagnosis t...
- Oral Cancer Foundation News Team: After sending this retrospective look to major can...
- hilllaguna: The mathematical probably that you have been expos...
- Why men’s health is a feminist issue
- BT Pharma secures EUR 13.1million (USD 17.7 million) in capital funding and changes its name to Genticel
- Cancer survivor tells his experience with smokeless tobacco
- Mayo oral cancer study shows full tumor genome
- Viagra, Cialis do more than arouse
- Avoid incense
- Transoral robotic surgery showed good oncologic, functional outcomes
- Prolonged treatment delay did not affect outcomes in SCCHN
- Instant screening device is the best defense for detecting deadly oral cancer
- New technology helps those affected by HPV
Follow OCF on these social networking sites connect to us, get involved, spread the knowledge, help the cause, change the world.
Tuesday, March 9, 2010
0 Comments